www.fdanews.com/articles/83034-teva-gets-final-approval-for-oxycodone-er-tablets
TEVA GETS FINAL APPROVAL FOR OXYCODONE ER TABLETS
December 9, 2005
The FDA has granted final approval to Teva Pharmaceutical's oxycodone extended-release
tablets in 10-, 20- and 40-mg dosage strengths. Oxycodone ER tablets are the
generic equivalent of Purdue Pharma's Oxycontin tablets, a product indicated
for the treatment of moderate-to-severe pain when continuous analgesia is needed
for an extended period of time.